hemangiol
pierre fabre medicament - пропранолол хидрохлорид - хемангиоми - Бета блокери - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
letrozole neo 2.5 mg film - coated tablets
МС ФАРМА АД, - Летрозол - 2.5 mg film - coated tablets
letrozol nucleus 2,5 mg film - coated tablets
actavis group ptc ehf.. - Летрозол - 2,5 mg film - coated tablets
letrofemin 2,5 mg film - coated tablets
Чайкафарма Висококачествените лекарства АД - Летрозол - 2,5 mg film - coated tablets
zequipra 2,5 mg film - coated tablets
НЕОЛА ФАРМА ЕООД - Летрозол - 2,5 mg film - coated tablets
letrocon 2,5 mg film - coated tablets
ФАРМАКОНС АД - Летрозол - 2,5 mg film - coated tablets
letrogen 2,5 mg film - coated tablets
generics /uk/ limited - Летрозол - 2,5 mg film - coated tablets
femara 2,5 mg film - coated tablets
novartis pharma gmbh - Летрозол - 2,5 mg film - coated tablets
etruzil 2.5 mg film - coated tablets
egis pharmaceuticals plc - Летрозол - 2.5 mg film - coated tablets
lortanda 2,5 mg film - coated tablets
krka, d.d. novo mesto - Летрозол - 2,5 mg film - coated tablets